KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Goodwill (2017 - 2019)

BeOne Medicines (ONC) reported Goodwill of $109000.0 for Q3 2019, little changed year-over-year from $109000.0 in Q3 2018, and little changed on a QoQ basis from $109000.0 in Q2 2019.

BeOne Medicines (ONC) has 3 years of Goodwill data on file, last reported at $109000.0 in Q3 2019.

  • Quarterly Goodwill changed 0.0% year-over-year to $109000.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $109000.0 (changed 0.0% YoY) and the FY2018 annual result came in at $109000.0, changed 0.0% from the prior year.
  • Goodwill held at $109000.0 in Q3 2019 per ONC's latest filing, from $109000.0 in the prior quarter.
  • Across five years, Goodwill topped out at $2.0 million in Q3 2017 and bottomed at $109000.0 in Q4 2017.
  • The 3-year median for Goodwill is $109000.0 (2017), against an average of $317333.3.
  • Peak annual rise in Goodwill reached 0.0% in 2018, while the deepest fall reached 94.51% in 2018.
  • Tracing ONC's Goodwill over 3 years: stood at $109000.0 in 2017, then changed by 0.0% to $109000.0 in 2018, then changed by 0.0% to $109000.0 in 2019.
  • Per Business Quant, the three latest ONC Goodwill figures stand at $109000.0 (Q3 2019), $109000.0 (Q2 2019), and $109000.0 (Q1 2019).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn -
5 Akari Therapeutics 605.66 Bn 605.66 Bn -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn
8 Evaxion A 65.12 Bn 65.10 Bn -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn
10 BeOne Medicines - - 1.35 Bn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2019 109,000.00
Jun 30, 2019 109,000.00
Mar 31, 2019 109,000.00
Dec 31, 2018 109,000.00
Sep 30, 2018 109,000.00
Jun 30, 2018 109,000.00
Mar 31, 2018 109,000.00
Dec 31, 2017 109,000.00
Sep 30, 2017 1.98 Mn